Skip to main content
. 2017 Jun 19;108(8):1565–1573. doi: 10.1111/cas.13280

Figure 5.

Figure 5

Immunohistochemical (IHC) analysis of dual‐specificity tyrosine‐regulated kinase 2 (DYRK2) expression in human colorectal liver metastases predicts clinical outcome. (a) Tissue specimens of colorectal cancer liver metastases were immunostained with anti‐DYRK2 antibodies. Scale bar = 25 μm. (b,c) Overall survival (b) and disease‐free survival (c) are shown. The groups with high and low expression of DYRK2 were compared.